Citace podle APA

Shen, G., Zheng, F., Ren, D., Du, F., Dong, Q., Wang, Z., . . . Zhao, J. (2018). Anlotinib: A novel multi-targeting tyrosine kinase inhibitor in clinical development. J Hematol Oncol.

Styl Chicago

Shen, Guoshuang, Fangchao Zheng, Dengfeng Ren, Feng Du, Qiuxia Dong, Ziyi Wang, Fuxing Zhao, Raees Ahmad, a Jiuda Zhao. "Anlotinib: A Novel Multi-targeting Tyrosine Kinase Inhibitor in Clinical Development." J Hematol Oncol 2018.

Citace podle MLA

Shen, Guoshuang, et al. "Anlotinib: A Novel Multi-targeting Tyrosine Kinase Inhibitor in Clinical Development." J Hematol Oncol 2018.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..